Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single‐institution retrospective study. Issue 11 (5th August 2022)
- Record Type:
- Journal Article
- Title:
- Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single‐institution retrospective study. Issue 11 (5th August 2022)
- Main Title:
- Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single‐institution retrospective study
- Authors:
- Konuthula, Neeraja
Do, Olivia A.
Gobillot, Ted
Rodriguez, Cristina P.
Futran, Neal D.
Houlton, Jeffrey
Barber, Brittany R. - Abstract:
- Abstract: Background: Survival outcomes in recurrent head and neck squamous cell carcinoma (HNSCC) are poor. This study aimed to compare survival outcomes between salvage surgery and immunotherapy in patients with recurrent advanced HNSCC. Methods: Patients with advanced stage (stage III or IV) recurrent HNSCC following treatment with platinum‐based chemotherapy were included. Survival was estimated using the Kaplan–Meier method, and Cox regression was used for multivariate logistic regression. Results: Two‐year overall survival after salvage surgery was 68.6% and after immunotherapy patients was 24.6%. Multivariate logistic regression showed that salvage surgery was associated with improved survival without statistical significance (hazard ratio [HR] 0.12, p = 0.25). Subgroup analysis of patients with oral cavity/oropharyngeal cancer noted improved survival with salvage surgery over immunotherapy (HR 0.006, p = 0.01) and decreased survival with neutrophil‐to‐lymphocyte ratio (NLR) > 5 (HR 6.4, p = 0.02). Conclusion: Our retrospective single‐institutional data suggest that resectable advanced stage recurrent HNSCC may have improved survival with salvage surgery in appropriately selected patients, but larger prospective studies are required.
- Is Part Of:
- Head & neck. Volume 44:Issue 11(2022)
- Journal:
- Head & neck
- Issue:
- Volume 44:Issue 11(2022)
- Issue Display:
- Volume 44, Issue 11 (2022)
- Year:
- 2022
- Volume:
- 44
- Issue:
- 11
- Issue Sort Value:
- 2022-0044-0011-0000
- Page Start:
- 2465
- Page End:
- 2472
- Publication Date:
- 2022-08-05
- Subjects:
- immunotherapy -- outcomes -- pembrolizumab -- recurrent head and neck cancer -- salvage surgery
Head -- Diseases -- Periodicals
Neck -- Diseases -- Periodicals
Head -- Periodicals
Neck -- Periodicals
Face -- Periodicals
617.51059 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0347 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/hed.27162 ↗
- Languages:
- English
- ISSNs:
- 1043-3074
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4274.608500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24037.xml